Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC

Odonate Therapeutics, Inc. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
breast-cancer
breast cancer, tesetaxel, capecitabine, her2 negative, combination of tesetaxel and capecitabine, taxane-naive, locally advanced or metastatic breast cancer, hormone receptor positive, metastatic breast cancer (mbc), central nervous system (cns) metastases, de novo metastatic breast cancer, oral chemotherapy
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 905221
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.